Theravance Biopharma (TBPH) Inventory Average (2014 - 2018)

Theravance Biopharma (TBPH) has 5 years of Inventory Average data on file, last reported at $17.9 million in Q3 2018.

• Inventory Average for Q3 2018 came in at $17.9 million, up 30.84% year-over-year; the trailing twelve-month figure through Sep 2018 was $17.9 million (up 30.84% YoY), and the FY2017 annual result was $14.5 million, up 30.71% from the prior year.
• Inventory Average advanced to $17.9 million in Q3 2018 per TBPH's latest filing, from $17.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $17.9 million in Q3 2018 and troughed at $9.6 million in Q2 2016.
• A 5-year average of $13.2 million and a median of $12.7 million in 2017 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2016 and 2018: Inventory Average slipped 22.8% in 2016, then soared 38.6% in 2018.
• A 5-year view of Inventory Average shows it stood at $13.8 million in 2014, then fell by 19.98% to $11.1 million in 2015, then rose by 11.53% to $12.4 million in 2016, then climbed by 29.91% to $16.0 million in 2017, then gained by 11.66% to $17.9 million in 2018.
• Business Quant data shows TBPH's Inventory Average at $17.9 million in Q3 2018, $17.6 million in Q2 2018, and $17.0 million in Q1 2018.